Ontology highlight
ABSTRACT: Background
High recurrence rate after curative treatment is the major problem for hepatocellular carcinoma (HCC). Cytokine-induced killer cells (CIKs) therapy was extensively studied among HCC patients. However, the value of CIKs therapy was controversial. A meta-analysis was performed to investigate the efficacy of adjuvant CIKs after invasive treatments among HCC patients.Methods
We searched online for literatures studying sequential CIKs therapy for HCC patients. Recurrence-free survival (RFS), progress-free survival (PFS) and overall survival (OS) were set as the main endpoints. Both overall and subgroup analysis were accomplished.Results
A total of 12 clinical trials with 1,387 patients were included. The pooled analysis showed a significant improvement of RFS,
SUBMITTER: Cai XR
PROVIDER: S-EPMC5458210 | biostudies-literature | 2017 May
REPOSITORIES: biostudies-literature